BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31142325)

  • 1. Content validity of the National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients.
    Krohe M; Tang DH; Klooster B; Revicki D; Galipeau N; Cella D
    Health Qual Life Outcomes; 2019 May; 17(1):92. PubMed ID: 31142325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
    Garcia SF; Rosenbloom SK; Beaumont JL; Merkel D; Von Roenn JH; Rao D; Cella D
    Value Health; 2012 Jan; 15(1):183-90. PubMed ID: 22264987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
    Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
    J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Paper-Based and Web-Based Versions of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16) Questionnaire in Breast Cancer Patients: Randomized Crossover Study.
    Ma J; Zou Z; Pazo EE; Moutari S; Liu Y; Jin F
    JMIR Med Inform; 2021 Mar; 9(3):e18269. PubMed ID: 33650978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
    Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
    Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining and supplementing candidate measures of psychological well-being for the NIH PROMISĀ®: qualitative results from a mixed cancer sample.
    Salsman JM; Park CL; Hahn EA; Snyder MA; George LS; Steger MF; Merluzzi T; Cella D
    Qual Life Res; 2018 Sep; 27(9):2471-2476. PubMed ID: 29926344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROMIS evaluation for head and neck cancer patients: a comprehensive quality-of-life outcomes assessment tool.
    Stachler RJ; Schultz LR; Nerenz D; Yaremchuk KL
    Laryngoscope; 2014 Jun; 124(6):1368-76. PubMed ID: 24719292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measures.
    Oude Voshaar MA; Ten Klooster PM; Glas CA; Vonkeman HE; Taal E; Krishnan E; Bernelot Moens HJ; Boers M; Terwee CB; van Riel PL; van de Laar MA
    Rheumatology (Oxford); 2015 Dec; 54(12):2221-9. PubMed ID: 26224306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT).
    Kaat AJ; Schalet BD; Rutsohn J; Jensen RE; Cella D
    Cancer; 2018 Jan; 124(1):153-160. PubMed ID: 28885707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.
    Herman JM; Kitchen H; Degboe A; Aldhouse NVJ; Trigg A; Hodgin M; Narang A; Johnson CD
    Qual Life Res; 2019 Nov; 28(11):2929-2939. PubMed ID: 31273624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey.
    van Wulfften Palthe ODR; Janssen SJ; Wunder JS; Ferguson PC; Wei G; Rose PS; Yaszemski MJ; Sim FH; Boland PJ; Healey JH; Hornicek FJ; Schwab JH
    Spine J; 2017 May; 17(5):636-644. PubMed ID: 27856381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis.
    Becker B; Raymond K; Hawkes C; Foster AM; Lovley A; Saucier C; Rizio AA; Bjorner JB; Kosinski M
    J Patient Rep Outcomes; 2021 Jul; 5(1):52. PubMed ID: 34228217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.
    Jensen RE; Potosky AL; Reeve BB; Hahn E; Cella D; Fries J; Smith AW; Keegan TH; Wu XC; Paddock L; Moinpour CM
    Qual Life Res; 2015 Oct; 24(10):2333-44. PubMed ID: 25935353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative study of patients with venous malformations: symptom experiences and content validity of patient-reported outcome measures.
    England RW; Bailey CR; Anatchkova MD; Skalicky AM; Meissner MH; Rosenblatt M; Gelhorn HL; Weiss CR
    Qual Life Res; 2020 Jun; 29(6):1707-1719. PubMed ID: 32020564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic center.
    Matthys MB; Dempsey AM; Melisko ME; Dreher N; Che ML; Van't Veer LJ; Esserman LJ; Basu A
    Cancer; 2021 Jul; 127(13):2342-2349. PubMed ID: 33957704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients.
    Tang E; Ekundayo O; Peipert JD; Edwards N; Bansal A; Richardson C; Bartlett SJ; Howell D; Li M; Cella D; Novak M; Mucsi I
    Qual Life Res; 2019 Mar; 28(3):815-827. PubMed ID: 30467780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    IsHak WW; Pan D; Steiner AJ; Feldman E; Mann A; Mirocha J; Danovitch I; Melmed GY
    Inflamm Bowel Dis; 2017 May; 23(5):798-803. PubMed ID: 28301432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROMIS and legacy measures compared in a supportive care intervention for breast cancer patients and caregivers: Experience from a randomized trial.
    Sikorskii A; Victorson D; O'Connor P; Hankin V; Safikhani A; Crane T; Badger T; Wyatt G
    Psychooncology; 2018 Sep; 27(9):2265-2273. PubMed ID: 29956396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.